BLACKROCK ADVISORS LLC - CELATOR PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
BLACKROCK ADVISORS LLC ownership history of CELATOR PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2016$718,000
+1951.4%
23,796
+639.9%
0.00%
Q1 2016$35,0003,2160.00%
Other shareholders
CELATOR PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
CAXTON CORP 2,246,469$3,729,0005.03%
TFS CAPITAL LLC 22,443$37,0000.00%
UBS Group AG 500$1,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 67,015$111,0000.00%
Tower Research Capital LLC (TRC) 25$00.00%
CITIGROUP INC 135$00.00%
NORTHERN TRUST CORP 20,724$35,0000.00%
GOLDMAN SACHS GROUP INC 34,795$58,0000.00%
WELLS FARGO & COMPANY/MN 2,200$4,0000.00%
MORGAN STANLEY 456$1,0000.00%
View complete list of CELATOR PHARMACEUTICALS INC shareholders